Compare Johnson Controls International PLC (JCI) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Johnson & Johnson — how do they compare? Johnson Controls International PLC trades at $142.46 (market cap $86.46B), while Johnson & Johnson trades at $255.9 (market cap $603.27B). The key difference: Johnson & Johnson is far larger — about 7× Johnson Controls International PLC's market cap, and Johnson & Johnson pays the higher dividend (2.14%). Which is the better fit depends on your goals.
| JCI | JNJ | |
|---|---|---|
Market Cap | $86.46B | $603.27B |
Sector | Industrials | Health |
52-Week High | $148.21 | $267.24 |
52-Week Low | $103.24 | $164.74 |
Enterprise Value | $95.28B | $636.21B |
Dividend Yield | 1.13% | 2.14% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson Controls International (JCI) trades at $141.71, up 0.89% with a bearish technical signal but strong analyst support. Recent earnings beats and a 14.45% net margin highlight operational strength, while valuation metrics like a P/E of 42.62 suggest premium pricing. The company maintains a dividend and benefits from positive news flow, including industry awards and strategic appointments.
Outlook is mixed: bullish fundamentals and analyst consensus target of $158.29 offer upside, but technical weakness and high valuation pose risks. Key drivers include execution in building systems and data center demand, while debt levels and economic sensitivity require monitoring for sustained growth.
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
